155 related articles for article (PubMed ID: 24305499)
1. Increased levels of plasma p3-alcα35, a major fragment of Alcadeinα by γ-secretase cleavage, in Alzheimer's disease.
Omori C; Kaneko M; Nakajima E; Akatsu H; Waragai M; Maeda M; Morishima-Kawashima M; Saito Y; Nakaya T; Taru H; Yamamoto T; Asada T; Hata S; Suzuki T;
J Alzheimers Dis; 2014; 39(4):861-70. PubMed ID: 24305499
[TBL] [Abstract][Full Text] [Related]
2. Coordinated increase of γ-secretase reaction products in the plasma of some female Japanese sporadic Alzheimer's disease patients: quantitative analysis of p3-Alcα with a new ELISA system.
Konno T; Hata S; Hamada Y; Horikoshi-Sakuraba Y; Nakaya T; Saito Y; Yamamoto T; Yamamoto T; Maeda M; Ikeuchi T; Gandy S; Akatsu H; Suzuki T;
Mol Neurodegener; 2011 Nov; 6():76. PubMed ID: 22067061
[TBL] [Abstract][Full Text] [Related]
3. Potential utility of soluble p3-alcadein α plasma levels as a biomarker for sporadic Alzheimer's disease.
Kamogawa K; Kohara K; Tabara Y; Takita R; Miki T; Konno T; Hata S; Suzuki T
J Alzheimers Dis; 2012; 31(2):421-8. PubMed ID: 22571980
[TBL] [Abstract][Full Text] [Related]
4. Multiple γ-secretase product peptides are coordinately increased in concentration in the cerebrospinal fluid of a subpopulation of sporadic Alzheimer's disease subjects.
Hata S; Taniguchi M; Piao Y; Ikeuchi T; Fagan AM; Holtzman DM; Bateman R; Sohrabi HR; Martins RN; Gandy S; Urakami K; Suzuki T;
Mol Neurodegener; 2012 Apr; 7():16. PubMed ID: 22534039
[TBL] [Abstract][Full Text] [Related]
5. Alternative processing of γ-secretase substrates in common forms of mild cognitive impairment and Alzheimer's disease: evidence for γ-secretase dysfunction.
Hata S; Fujishige S; Araki Y; Taniguchi M; Urakami K; Peskind E; Akatsu H; Araseki M; Yamamoto K; Martins RN; Maeda M; Nishimura M; Levey A; Chung KA; Montine T; Leverenz J; Fagan A; Goate A; Bateman R; Holtzman DM; Yamamoto T; Nakaya T; Gandy S; Suzuki T
Ann Neurol; 2011 Jun; 69(6):1026-31. PubMed ID: 21681798
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.
Hansson O; Zetterberg H; Vanmechelen E; Vanderstichele H; Andreasson U; Londos E; Wallin A; Minthon L; Blennow K
Neurobiol Aging; 2010 Mar; 31(3):357-67. PubMed ID: 18486992
[TBL] [Abstract][Full Text] [Related]
7. [Molecular Pathogenesis of Sporadic Alzheimer's Disease (AD) and Pharmaceutical Research to Develop a Biomarker for AD Diagnosis].
Hata S
Yakugaku Zasshi; 2015; 135(9):1023-7. PubMed ID: 26329547
[TBL] [Abstract][Full Text] [Related]
8. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease.
Hampel H; Shen Y
Scand J Clin Lab Invest; 2009; 69(1):8-12. PubMed ID: 18609117
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of intramembrane cleavage of alcadeins by γ-secretase.
Piao Y; Kimura A; Urano S; Saito Y; Taru H; Yamamoto T; Hata S; Suzuki T
PLoS One; 2013; 8(4):e62431. PubMed ID: 23658629
[TBL] [Abstract][Full Text] [Related]
10. A new sandwich immunoassay for detection of the α-secretase cleaved, soluble amyloid-β protein precursor in cerebrospinal fluid and serum.
Taverna M; Straub T; Hampel H; Rujescu D; Lichtenthaler SF
J Alzheimers Dis; 2013; 37(4):667-78. PubMed ID: 23948916
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic fragment of Alcadein α generated by regulated intramembrane proteolysis enhances amyloid β-protein precursor (APP) transport into the late secretory pathway and facilitates APP cleavage.
Takei N; Sobu Y; Kimura A; Urano S; Piao Y; Araki Y; Taru H; Yamamoto T; Hata S; Nakaya T; Suzuki T
J Biol Chem; 2015 Jan; 290(2):987-95. PubMed ID: 25406318
[TBL] [Abstract][Full Text] [Related]
12. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ
J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051
[TBL] [Abstract][Full Text] [Related]
13. Are γ-secretase and its associated Alzheimer's disease γ problems?
Rodríguez-Manotas M; Amorín-Díaz M; Cabezas-Herrera J; Acedo-Martínez A; Llorca-Escuín I
Med Hypotheses; 2012 Feb; 78(2):299-304. PubMed ID: 22133557
[TBL] [Abstract][Full Text] [Related]
14. Evidence that the amyloid-β protein precursor intracellular domain, AICD, derives from β-secretase-generated C-terminal fragment.
Flammang B; Pardossi-Piquard R; Sevalle J; Debayle D; Dabert-Gay AS; Thévenet A; Lauritzen I; Checler F
J Alzheimers Dis; 2012; 30(1):145-53. PubMed ID: 22406447
[TBL] [Abstract][Full Text] [Related]
15. Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease.
Tang K; Hynan LS; Baskin F; Rosenberg RN
J Neurol Sci; 2006 Jan; 240(1-2):53-8. PubMed ID: 16256140
[TBL] [Abstract][Full Text] [Related]
16. BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.
Mulder SD; van der Flier WM; Verheijen JH; Mulder C; Scheltens P; Blankenstein MA; Hack CE; Veerhuis R
J Alzheimers Dis; 2010; 20(1):253-60. PubMed ID: 20164582
[TBL] [Abstract][Full Text] [Related]
17. Alcadein cleavages by amyloid beta-precursor protein (APP) alpha- and gamma-secretases generate small peptides, p3-Alcs, indicating Alzheimer disease-related gamma-secretase dysfunction.
Hata S; Fujishige S; Araki Y; Kato N; Araseki M; Nishimura M; Hartmann D; Saftig P; Fahrenholz F; Taniguchi M; Urakami K; Akatsu H; Martins RN; Yamamoto K; Maeda M; Yamamoto T; Nakaya T; Gandy S; Suzuki T
J Biol Chem; 2009 Dec; 284(52):36024-36033. PubMed ID: 19864413
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
19. Decrease in p3-Alcβ37 and p3-Alcβ40, products of Alcadein β generated by γ-secretase cleavages, in aged monkeys and patients with Alzheimer's disease.
Hata S; Omori C; Kimura A; Saito H; Kimura N; Gupta V; Pedrini S; Hone E; Chatterjee P; Taddei K; Kasuga K; Ikeuchi T; Waragai M; Nishimura M; Hu A; Nakaya T; Meijer L; Maeda M; Yamamoto T; Masters CL; Rowe CC; Ames D; Yamamoto K; Martins RN; Gandy S; Suzuki T
Alzheimers Dement (N Y); 2019; 5():740-750. PubMed ID: 31754625
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
